Jennison Associates LLC Sells 41,798 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Jennison Associates LLC decreased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 14.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 251,790 shares of the company's stock after selling 41,798 shares during the quarter. Jennison Associates LLC owned 0.51% of Prestige Consumer Healthcare worth $21,646,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in PBH. Kayne Anderson Rudnick Investment Management LLC acquired a new position in Prestige Consumer Healthcare during the 4th quarter worth approximately $84,932,000. Raymond James Financial Inc. bought a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth $42,593,000. Norges Bank acquired a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth $40,009,000. Bessemer Group Inc. lifted its stake in shares of Prestige Consumer Healthcare by 10,053.1% in the 4th quarter. Bessemer Group Inc. now owns 295,050 shares of the company's stock valued at $23,041,000 after acquiring an additional 292,144 shares during the last quarter. Finally, BNP Paribas Financial Markets boosted its holdings in shares of Prestige Consumer Healthcare by 1,073.3% during the 4th quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company's stock valued at $15,923,000 after acquiring an additional 186,524 shares in the last quarter. Institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Down 0.6%

Shares of NYSE PBH traded down $0.44 during trading on Thursday, reaching $76.29. The company had a trading volume of 269,927 shares, compared to its average volume of 444,294. The stock has a market cap of $3.77 billion, a P/E ratio of 17.78, a PEG ratio of 2.30 and a beta of 0.43. The company's fifty day moving average price is $82.06 and its 200-day moving average price is $82.24. The company has a quick ratio of 2.82, a current ratio of 4.20 and a debt-to-equity ratio of 0.55. Prestige Consumer Healthcare Inc. has a 12 month low of $64.94 and a 12 month high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The business had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. During the same period in the prior year, the business posted $1.02 earnings per share. The firm's revenue was up 7.0% on a year-over-year basis. As a group, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Wall Street Zen upgraded Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.